000 01715 a2200457 4500
005 20250515201156.0
264 0 _c20100315
008 201003s 0 0 eng d
022 _a1520-4383
024 7 _a10.1182/asheducation-2009.1.362
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLitzow, Mark R
245 0 0 _aEvolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.
_h[electronic resource]
260 _bHematology. American Society of Hematology. Education Program
_c2009
300 _a362-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aClinical Trials as Topic
_xstatistics & numerical data
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Delivery Systems
650 0 4 _aGraft vs Leukemia Effect
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMeta-Analysis as Topic
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aRemission Induction
650 0 4 _aSurvival Rate
650 0 4 _aTransplantation Conditioning
650 0 4 _aTransplantation, Homologous
650 0 4 _aYoung Adult
773 0 _tHematology. American Society of Hematology. Education Program
_gp. 362-70
856 4 0 _uhttps://doi.org/10.1182/asheducation-2009.1.362
_zAvailable from publisher's website
999 _c19390153
_d19390153